Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of LX2006 Gene Therapy in Friedreich Ataxia Cardiomyopathy
Sponsor: Lexeo Therapeutics
Summary
The purpose of Study LX2006-03, a multicenter, Phase 2, open-label, randomized, controlled study, is to evaluate the efficacy and safety of LX2006 gene therapy in participants with Friedreich ataxia (FA) cardiomyopathy (CM).
Official title: A Phase 2, Multicenter, Open-label, Randomized, Controlled Study of LX2006 Gene Therapy in Participants With Friedreich Ataxia Cardiomyopathy (SUNRISE-FA 2)
Key Details
Gender
All
Age Range
6 Years - Any
Study Type
INTERVENTIONAL
Enrollment
26
Start Date
2026-06-25
Completion Date
2032-06
Last Updated
2026-11-17
Healthy Volunteers
No
Interventions
LX2006
Adeno-associated viral vector encoding the FXN gene (AAVrh.10hFXN)
Usual Care
Cohort 1: Participants ≥16 years of age with FA-CM Participants will receive usual care for 26 weeks before receiving treatment with LX2006 (single crossover).
Locations (22)
Arkansas Children's
Little Rock, Arkansas, United States
University of California San Diego
La Jolla, California, United States
Ataxia Center and HD Center of Excellence (UCLA)
Los Angeles, California, United States
University of South Florida
Tampa, Florida, United States
Indiana University
Indianapolis, Indiana, United States
Boston Children's Hospital
Boston, Massachusetts, United States
Mayo Clinic
Rochester, Minnesota, United States
Washington University School of Medicine
St Louis, Missouri, United States
Cincinnati Children's Hospital
Cincinnati, Ohio, United States
Hospital Universitário Walter Cantídio - Universidade Federal do Ceará
Fortaleza, Ceará, Brazil
Instituto D'Or de Pesquisa e Ensino - Hospital São Rafael
Salvador, Estado de Bahia, Brazil
Hospital das Clínicas da Universidade Federal de Minas Gerais (UFMG)
Belo Horizonte, Minas Gerais, Brazil
Campinas State University (UNICAMP)
Campinas, São Paulo, Brazil
UPC Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto
Ribeirão Preto, São Paulo, Brazil
Centre hospitalier de l'Université de Montréal (CHUM)
Montreal, Quebec, Canada
Motol University Hospital and the Second Faculty of Medicine
Prague, Czechia
Institut de Cardiologie, Hôpital Pitié-Salpêtrière
Paris, France
University Hospital Tübingen, Department of Neurology
Tübingen, Baden-Wurttemberg, Germany
Federico II University
Naples, Italy, Italy
Hospital Universitario Puerta de Hierro Majadahonda
Majadahonda, Madrid, Spain
St. Bartholomew's Hospital
London, United Kingdom
Imperial College Healthcare NHS Trust
London, United Kingdom